[Pharmaceutical and Bio News] SK Bioscience signs contract for contract manufacturing of MSD Ebola vaccine
SK Bioscience announced a partnership with global pharmaceutical company MSD to participate in the development project for an Ebola vaccine supported by CEPI.
Vaccine Damage: Plaintiff Achieves Intermediate Victory Against Astra Zeneca
A German court ruled that a plaintiff can seek damages from Astra Zeneca for vaccine-related injuries, marking a significant development in her case.
The Controversy Over Foreign Substances in COVID-19 Vaccines Should Be Understood in Context Rather Than as an Isolated Phenomenon
Recent reports of foreign substances in COVID-19 vaccines have raised public concern about the safety of the vaccines, emphasizing the need for a thorough understanding of the vaccine development and distribution process.
The security and innovation of vaccines in Brazil
The article discusses Brazil's approach to vaccine innovation and the implications for public health and economic development, emphasizing the importance of national sovereignty in health-related innovations.
South Africa: Foot-and-Mouth Disease Vaccine Signals a Turning Point for SA Agriculture
The arrival of Foot-and-Mouth Disease vaccines in South Africa is seen as a crucial development for the country's agricultural sector, enhancing economic growth and job creation.
A step away from a revolution in medicine? "I think we have a universal vaccine"
Researchers from Stanford Medicine and collaborating institutions are testing a new approach to vaccines that could lead to the development of a universal vaccine.
Leader: Because of Trump, there might be no vaccine for cancer
The article discusses how Donald Trump's political actions in the U.S. may impede the development of a promising cancer vaccine based on mRNA technology.
A Spaniard leads a breakthrough that could accelerate the HIV vaccine
A Spanish scientist has made significant progress that could lead to accelerated development of an HIV vaccine, pending funding for human trials.